High antimalarial efficacy of dihydroartemisinin-piperaquine on the China-myanmar border: The calm before the storm

American Journal of Tropical Medicine and Hygiene

Volumn 93, Issue 3, 2015, Pages 436-437

  Fairhurst, Rick M ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; ARTESUNATE; ARTESUNATE PLUS MEFLOQUINE; ARTESUNATE PLUS PYRONARIDINE; DIHYDROARTEMISININ PLUS PIPERAQUINE; MEFLOQUINE; PRIMAQUINE; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; DIHYDROARTEMISININ; PIPERAQUINE; QUINOLINE DERIVATIVE;

ANTIMALARIAL ACTIVITY; ANTIMALARIAL DRUG RESISTANCE; CAMBODIA; CHINA; DRUG EFFICACY; EDITORIAL; GAMETOCYTE; GENE MUTATION; GENETIC MARKER; HUMAN; MALARIA CONTROL; MALARIA FALCIPARUM; MIGRATION; MONOTHERAPY; MORBIDITY; MORTALITY; MYANMAR; PARASITE CLEARANCE; DRUG COMBINATION; DRUG EFFECTS; DRUG RESISTANCE; EPIDEMIOLOGY; GENETICS; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; TREATMENT OUTCOME;

ANTIMALARIALS; ARTEMISININS; CHINA; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; HUMANS; MALARIA, FALCIPARUM; MYANMAR; PLASMODIUM FALCIPARUM; QUINOLINES; TREATMENT OUTCOME;

EID: 84941654269     PISSN: 00029637     EISSN: 14761645     Source Type: Journal    
DOI: 10.4269/ajtmh.15-0349     Document Type: Editorial

References (10)

1. Wang Y, Yang Z, Yuan L, Zhou G, Parker D, Lee MC, Yan G, Fan Q, Xiao Y, Cao Y, Cui L, 2015. Clinical efficacy of dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria at the China-Myanmar border. Am J Trop Med Hyg 93: 577-583.
2. Sun XD, Zhang ZX, Wang J, Deng Y, Yang YC, Lasi JH, Sun XY, Wang H, 2011. Therapeutic efficacy and safety of compound dihydroartemisinin/piperaquine for uncomplicated Plasmodium falciparum infection in Laiza City of Myanmar bordering on China. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 29: 372-375.
3. Huang F, Tang L, Yang H, Zhou S, Sun X, Liu H, 2012. Therapeutic efficacy of artesunate in the treatment of uncomplicated Plasmodium falciparum malaria and anti-malarial, drug-resistance marker polymorphisms in populations near the China-Myanmar border. Malar J 11: 278.
4. Bustos MD, Wongsrichanalai C, Delacollette C, Burkholder B, 2013. Monitoring antimalarial drug efficacy in the Greater Mekong Subregion: an overview of in vivo results from 2008 to 2010. The Southeast Asian J Trop Med Public Health 44 (Suppl 1): 201-230; discussion 306-207.
5. Huang F, Takala-Harrison S, Jacob CG, Liu H, Sun X, Yang H, Nyunt MM, Adams M, Zhou S, Xia Z, Ringwald P, Bustos MD, Tang L, Plowe CV, 2015. A single mutation in K13 predominates in southern China and is associated with delayed clearance of Plasmodium falciparum following artemisinin treatment. J Infect Dis. 2015 Apr 24 [Epub ahead of print].
6. Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois AC, Khim N, Kim S, Duru V, Bouchier C, Ma L, Lim P, Leang R, Duong S, Sreng S, Suon S, Chuor CM, Bout DM, Ménard S, Rogers WO, Genton B, Fandeur T, Miotto O, Ringwald P, Le Bras J, Berry A, Barale JC, Fairhurst RM, Benoit-Vical F, Mercereau-Puijalon O, Ménard D, 2014. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature 505: 50-55.
7. Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, Sreng S, Anderson JM, Mao S, Sam B, Sopha C, Chuor CM, Nguon C, Sovannaroth S, Pukrittayakamee S, Jittamala P, Chotivanich K, Chutasmit K, Suchatsoonthorn C, Runcharoen R, Hien TT, Thuy-Nhien NT, Thanh NV, Phu H, Htut Y, Han KT, Aye KH, Mokuolu OA, Olaosebikan RR, Folaranmi OO, Mayxay M, Khanthavong M, Hongvanthong B, Newton PN, Onyamboko MA, Fanello CI, Tshefu AK, Mishra N, Valecha N, Phyo AP, Nosten F, Yi P, Tripura R, Borrmann S, Bashraheil M, Peshu J, Faiz MA, Ghose A, Hossain MA, Samad R, Rahman MR, Hasan MM, Islam A, Miotto O, Amato R, MacInnis B, Stalker J, Kwiatkowski DP, Bozdech Z, Jeeyapant A, Cheah PY, Sakulthaew T, Chalk J, Intharabut B, Silamut K, Lee SJ, Vihokhern B, Kunasol C, Imwong M, Tarning J, Taylor WJ, Yeung S, Woodrow CJ, Flegg JA, Das D, Smith J, Venkatesan M, Plowe CV, Stepniewska K, Guerin J, Dondorp AM, Day NP, White NJ; Tracking Resistance to Artemisinin Collaboration (TRAC), 2014. Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 371: 411-423.
8. Leang R, Barrette A, Bouth DM, Menard D, Abdur R, Duong S, Ringwald P, 2013. Efficacy of dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum and Plasmodium vivax in Cambodia, 2008 to 2010. Antimicrob Agents Chemother 57: 818-826.
9. Spring MD, Lin JT, Manning JE, Vanachayangkul P, Somethy S, Bun R, Se Y, Chann S, Ittiverakul M, Sia-Ngam P, Kuntawunginn W, Arsanok M, Buathong N, Chaorattanakawee S, Gosi P, Ta-Aksorn W, Chanarat N, Sundrakes S, Kong N, Heng TK, Nou S, Teja-Isavadharm P, Pichyangkul S, Phann ST, Balasubramanian S, Juliano JJ, Meshnick SR, Chour CM, Prom S, Lanteri CA, Lon C, Saunders DL, 2015. Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study. Lancet Infect Dis. 2015 Apr 10 [Epub ahead of print].
10. Lim P, Dek D, Try V, Sreng S, Suon S, Fairhurst RM, 2015. Decreasing pfmdr1 copy number suggests that Plasmodium falciparum in western Cambodia is regaining in vitro susceptibility to mefloquine. Antimicrob Agents Chemother 59: 2934-2937.